Cibus CBUS
NASDAQ CBUS
$1.70 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cibus (CBUS) Other Non-Current Liabilities (2016 - 2026)

Cibus (CBUS) posted Other Non-Current Liabilities of $1.6 million for Q4 2025, up 1.56% sequentially from $1.5 million in Q3 2025, and down 99.22% YoY from $199.4 million in Q4 2024.

Cibus (CBUS) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends

Cibus has reported Other Non-Current Liabilities for 10 years, with the latest figure at $1.6 million in Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 99.22% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 99.22% YoY) and the FY2025 annual result came in at $1.6 million, down 99.22% from the prior year.
  • Other Non-Current Liabilities climbed to $1.6 million in Q4 2025 per CBUS's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $199.4 million in Q4 2024 and troughed at $61000.0 in Q1 2023.
  • A 5-year average of $64.6 million and a median of $1.5 million in 2025 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 284459.02% in 2024, then tumbled 99.22% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $702000.0 in 2021, then sank by 88.6% to $80000.0 in 2022, then jumped by 206465.0% to $165.3 million in 2023, then climbed by 20.69% to $199.4 million in 2024, then sank by 99.22% to $1.6 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.6 million, $1.5 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Cibus 129.72 Mn 109.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 253.52 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 199.44 Mn
Sep 30, 2024 191.21 Mn
Jun 30, 2024 182.33 Mn
Mar 31, 2024 173.58 Mn
Dec 31, 2023 165.25 Mn
Sep 30, 2023 157.11 Mn
Jun 30, 2023 148.98 Mn
Mar 31, 2023 61,000.00
Sep 30, 2022 80,000.00
Jun 30, 2022 68,000.00
Mar 31, 2022 73,000.00
Dec 31, 2021 702,000.00
Sep 30, 2021 971,000.00
Jun 30, 2021 1.04 Mn
Mar 31, 2021 1.21 Mn